Antifungal therapy – Page 11

Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model

mycolabadmin

Researchers developed special nanoparticles that can cross the protective barrier surrounding the brain by using a protein from a fungal infection. These nanoparticles are loaded with an antifungal drug and can effectively treat cryptococcal brain infections in laboratory tests. This approach offers a new way to deliver medicines to the brain without invasive procedures, potentially helping patients with serious brain infections that are currently difficult to treat.

Acute fungal endometritis in women with abnormal uterine bleeding: Clinical and microbiological insights

mycolabadmin

Women with persistent abnormal uterine bleeding often undergo extensive testing without finding a cause. This study discovered that fungal infections, caused by Candida species, may be responsible for about 12% of such cases. The researchers found that direct sampling of the uterine lining is essential for diagnosis since surface vaginal cultures miss these infections. Treatment with an antifungal medication called voriconazole combined with surgical cleaning of the uterus proved effective in resolving the condition.

Pulmonary Mucormycosis in Diabetic Patients: A Case Series From a Tertiary Respiratory Center in Sri Lanka

mycolabadmin

This case study describes three patients with diabetes who developed a serious lung infection caused by a rare fungus called mucormycosis. The infection presented with various symptoms like cough, fever, and weight loss, and was diagnosed using lung tissue samples that showed the characteristic fungal structures. Two patients recovered with prolonged antifungal medication treatment, while one patient unfortunately died despite receiving prompt treatment, highlighting how serious this infection can be.

Black mold in the bag room: First case of Arthrocladium tropicale peritonitis in a peritoneal dialysis patient

mycolabadmin

An 82-year-old dialysis patient developed an unusual infection caused by a black mold called Arthrocladium tropicale, which had never been documented in humans before. The infection was traced to poor storage conditions and ant infestations near the patient’s dialysis supplies in Thailand during rainy season. Doctors identified the rare fungus using molecular genetic testing and treated it successfully with antifungal medication combined with removal of the dialysis catheter. This case highlights the importance of keeping dialysis equipment in clean, dry environments and preventing pest access to prevent serious infections.

A case report of childhood onychomycosis caused by the rare yeast Kodamaea ohmeri

mycolabadmin

A 5-year-old girl in Vietnam developed a nail infection caused by a rare yeast called Kodamaea ohmeri, which typically affects adults with diabetes or weak immune systems. The infection, appearing as white discoloration on the nails, was successfully treated with a topical antifungal cream applied three times daily for one month. This is the first reported case of this rare yeast causing nail infection in a child in Vietnam, and it demonstrates that topical treatment can be effective for fungal nail infections in children whose nails are thinner than adults.

Rasamsonia argillacea brain abscess in a lung transplant recipient: an unexpected infection by an unusual fungal pathogen

mycolabadmin

A 65-year-old woman who received a lung transplant developed a rare and serious brain infection caused by an unusual fungus called Rasamsonia argillacea. The infection was difficult to diagnose because it looks similar to more common molds under the microscope. During the investigation of this unexpected infection, doctors discovered that the patient had a rare genetic disorder affecting her immune system that had never been diagnosed. This case highlights how unusual infections can reveal hidden immune system problems.

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

mycolabadmin

Dr. John Perfect, a leading infectious disease expert, discusses his 48-year career studying fungal infections, particularly cryptococcal meningitis. He reflects on the dramatic transformation of HIV/AIDS from a fatal disease to a manageable chronic condition and emphasizes that antifungal resistance is less concerning than the underlying diseases that complicate treatment. Perfect advocates for developing more potent antifungal drugs that work faster, and discusses promising approaches like molecular diagnostics and immune-based therapies to improve patient outcomes.

The 2024 International Society for Human and Animal Mycology (ISHAM)-ABPA working group guidelines: Transforming diagnosis and management of ABPA

mycolabadmin

Allergic bronchopulmonary aspergillosis (ABPA) is a serious lung condition that develops when people with asthma have an allergic reaction to Aspergillus fungus. New international guidelines now provide better ways to diagnose and treat this condition, making it easier for doctors to identify ABPA early and prescribe the right treatment to prevent serious lung damage like bronchiectasis.

Inappropriate treatment of pulmonary aspergillosis caused by Aspergillus flavus in susceptible pediatric patients: a case series

mycolabadmin

This case series describes three children in Iran who developed serious lung infections caused by a fungal organism called Aspergillus flavus. Tragically, two of the three children died because their infections were diagnosed too late and they did not receive appropriate antifungal medications. The study emphasizes that children with weakened immune systems need quick diagnosis and proper antifungal treatment to survive these dangerous fungal infections.

Assessing Diagnostic Capabilities and Treatment Accessibility for Invasive Fungal Infections in the Balkan Region

mycolabadmin

Researchers surveyed medical centers across 12 Balkan countries to understand how well-equipped they are to diagnose and treat serious fungal infections. They found that while most centers have basic laboratory tools like microscopes and cultures, advanced molecular tests for identifying fungal species are less common. Antifungal medications like triazoles are widely available, but other important treatment options are harder to find in the region.

Research Topic: Antifungal therapy